NCT07606157

Brief Summary

Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear. This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis. A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 26, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

June 20, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2026

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2027

Last Updated

May 26, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 7, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

osteoarthritisphysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Kinesiophobia

    Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ). The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement. The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.

    4 weeks

Secondary Outcomes (4)

  • Pain intensity

    4 weeks

  • Functional status

    4 weeks

  • Functional mobility

    4 weeks

  • Dynamic balance

    4 weeks

Study Arms (1)

Kinesiotaping

EXPERIMENTAL

Kinesiotaping

Other: Kinesiotaping

Interventions

Kinesiotaping

Kinesiotaping

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of unilateral grade 2 knee osteoarthritis,
  • Age between 40 and 65 years,
  • Ability to understand and comply with assessments and interventions,
  • Independent ambulation without assistive devices,
  • No participation in a physiotherapy program for knee-related complaints within the previous year

You may not qualify if:

  • History of lower extremity surgery or trauma,
  • Presence of neurological or orthopedic conditions affecting gait or physical function,
  • Allergic reaction to kinesiotape,
  • Inability to walk independently.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Cigercioglu

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

May 7, 2026

First Posted

May 26, 2026

Study Start (Estimated)

June 20, 2026

Primary Completion (Estimated)

December 20, 2026

Study Completion (Estimated)

June 20, 2027

Last Updated

May 26, 2026

Record last verified: 2026-05